Sol-Gel Technologies (SLGL) Net Margin Growth (3y) (2021 - 2025)

Sol-Gel Technologies (SLGL) Net Margin Growth (3y) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,283.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -569.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 6,537.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 4.20 Mn
Sep 30, 2025 -157,200.00
Jun 30, 2025 6,125.00
Mar 31, 2025 85,413.00
Dec 31, 2024 -2.01 Mn
Sep 30, 2024 -1,544.00
Jun 30, 2024 -83,573.00
Dec 31, 2023 -1.19 Mn
Sep 30, 2023 -268,122.00
Jun 30, 2023 38,104.00
Dec 31, 2022 -5.11 Mn
Sep 30, 2022 -15,536.00
Jun 30, 2022 -5,940.00
Mar 31, 2022 -8,990.00
Dec 31, 2021 59.38 Mn
Sep 30, 2021 -2.03 Mn
Jun 30, 2021 -1.32 Mn
Mar 31, 2021 -1.24 Mn